Literature DB >> 24173814

Permeation and metabolism of Alternaria mycotoxins with perylene quinone structure in cultured Caco-2 cells.

Stefanie C Fleck1, Erika Pfeiffer, Manfred Metzler.   

Abstract

The absorption of four Alternaria toxins with perylene quinone structures, i.e. altertoxin (ATX) I and II, alteichin (ALTCH) and stemphyltoxin (STTX) III, has been determined in the Caco-2 cell Transwell system, which represents a widely accepted in vitro model for human intestinal absorption and metabolism. The cells were incubated with the four mycotoxins on the apical side, and the concentration of the toxins in the incubation media of both chambers and in the cell lysate were determined by liquid chromatography coupled with diode array detection and mass spectrometry (LC-DAD-MS) analysis. ATX I and ALTCH were not metabolised in Caco-2 cells, but ATX II and STTX III were partly biotransformed by reductive de-epoxidation to the metabolites ATX I and ALTCH, respectively. Based on the apparent permeability coefficients (Papp), the following ranking order for the permeation into the basolateral compartment was obtained: ATX I > ALTCH >> ATX II > STTX III. Total recovery of the four toxins decreased in the same order. It is assumed that the losses of STTX III, ATX II and ALTCH in Caco-2 cells are caused by covalent binding to cell components due to the epoxide group and/or the α,β-unsaturated carbonyl group present in these toxins. We conclude from this study that ATX I and ALTCH are well absorbed from the intestinal lumen into the portal blood in vivo. For ATX II and STTX III, intestinal absorption of the parent toxins is very low, but these toxins are partly metabolised to ATX I and ALTCH, respectively, in the intestinal epithelium and absorbed as such.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24173814     DOI: 10.1007/s12550-013-0180-0

Source DB:  PubMed          Journal:  Mycotoxin Res        ISSN: 0178-7888            Impact factor:   3.833


  13 in total

Review 1.  The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics.

Authors:  Y Sambuy; I De Angelis; G Ranaldi; M L Scarino; A Stammati; F Zucco
Journal:  Cell Biol Toxicol       Date:  2005-01       Impact factor: 6.691

Review 2.  Permeability for intestinal absorption: Caco-2 assay and related issues.

Authors:  Barry Press; Deanna Di Grandi
Journal:  Curr Drug Metab       Date:  2008-11       Impact factor: 3.731

3.  In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth.

Authors:  S Yee
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

4.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

5.  Further examination of the effects of nitrosylation on Alternaria alternata mycotoxin mutagenicity in vitro.

Authors:  T J Schrader; W Cherry; K Soper; I Langlois
Journal:  Mutat Res       Date:  2006-05-15       Impact factor: 2.433

6.  Alternaria toxins: Altertoxin II is a much stronger mutagen and DNA strand breaking mycotoxin than alternariol and its methyl ether in cultured mammalian cells.

Authors:  Stefanie C Fleck; Britta Burkhardt; Erika Pfeiffer; Manfred Metzler
Journal:  Toxicol Lett       Date:  2012-08-10       Impact factor: 4.372

7.  Mutagenic perylenequinone metabolites of Alternaria alternata: altertoxins I, II, and III.

Authors:  M E Stack; E P Mazzola; S W Page; A E Pohland; R J Highet; M S Tempesta; D G Corley
Journal:  J Nat Prod       Date:  1986 Sep-Oct       Impact factor: 4.050

8.  Relationships between Alternaria alternata and oesophageal cancer.

Authors:  G T Liu; Y Z Qian; P Zhang; Z M Dong; Z Y Shi; Y Z Zhen; J Miao; Y M Xu
Journal:  IARC Sci Publ       Date:  1991

9.  Etiological role of Alternaria alternata in human esophageal cancer.

Authors:  G T Liu; Y Z Qian; P Zhang; W H Dong; Y M Qi; H T Guo
Journal:  Chin Med J (Engl)       Date:  1992-05       Impact factor: 2.628

10.  Stemphyltoxin III from Alternaria alternata.

Authors:  M E Stack; E P Mazzola
Journal:  J Nat Prod       Date:  1989 Mar-Apr       Impact factor: 4.050

View more
  6 in total

1.  Spotlight on the Underdogs-An Analysis of Underrepresented Alternaria Mycotoxins Formed Depending on Varying Substrate, Time and Temperature Conditions.

Authors:  Theresa Zwickel; Sandra M Kahl; Horst Klaffke; Michael Rychlik; Marina E H Müller
Journal:  Toxins (Basel)       Date:  2016-11-19       Impact factor: 4.546

2.  In vitro interactions of Alternaria mycotoxins, an emerging class of food contaminants, with the gut microbiota: a bidirectional relationship.

Authors:  Francesco Crudo; Georg Aichinger; Jovana Mihajlovic; Elisabeth Varga; Luca Dellafiora; Benedikt Warth; Chiara Dall'Asta; David Berry; Doris Marko
Journal:  Arch Toxicol       Date:  2021-04-13       Impact factor: 5.153

3.  Alternaria alternata Toxins Synergistically Activate the Aryl Hydrocarbon Receptor Pathway In Vitro.

Authors:  Julia Hohenbichler; Georg Aichinger; Michael Rychlik; Giorgia Del Favero; Doris Marko
Journal:  Biomolecules       Date:  2020-07-09

4.  Functional impairment triggered by altertoxin II (ATXII) in intestinal cells in vitro: cross-talk between cytotoxicity and mechanotransduction.

Authors:  Giorgia Del Favero; Ronita Zaharescu; Doris Marko
Journal:  Arch Toxicol       Date:  2018-10-01       Impact factor: 5.153

5.  Chemotaxonomy of Mycotoxigenic Small-Spored Alternaria Fungi - Do Multitoxin Mixtures Act as an Indicator for Species Differentiation?

Authors:  Theresa Zwickel; Sandra M Kahl; Michael Rychlik; Marina E H Müller
Journal:  Front Microbiol       Date:  2018-07-03       Impact factor: 5.640

Review 6.  Mycotoxins: Biotransformation and Bioavailability Assessment Using Caco-2 Cell Monolayer.

Authors:  Van Nguyen Tran; Jitka Viktorová; Tomáš Ruml
Journal:  Toxins (Basel)       Date:  2020-09-30       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.